ICUI — ICU Medical, Inc. stock price, charts and financials

QT59ICU Medical, Inc.

ICU Medical, Inc. (NASDAQ: ICUI) is a Healthcare company in the Medical - Instruments & Supplies industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
171.96
-0.98-0.57%
ICUIQT59ICU Medical, Inc.·NASDAQ
171.96-0.57%
TA
Loading chart...
Screen all →
Snapshot
Index-P/E92.95EPS (ttm)1.85Insider Own18.76%Shs Outstand24.99MPerf Week3.73%
Market Cap4.30BForward P/E18.48EPS next Y9.31Insider Trans-0.15%Shs Float24.50MPerf Month7.86%
Enterprise Value5.35BPEG11.69EPS next Q-Inst Own-Short Float7.48%Perf Quarter44.91%
Income46.00MP/S1.99EPS this Y341.36%Inst Trans-Short Ratio6.10Perf Half Y13.54%
Sales2.16BP/B2.03EPS next Y13.97%ROA1.15%Short Interest1.83MPerf YTD20.53%
Book/sh84.50P/C14.92EPS next 5Y7.95%ROE2.19%52W High176.28 -2.45%Perf Year34.98%
Cash/sh11.52P/FCF52.39EPS past 3/5Y- -62.60%ROIC2.27%52W Low107.00 60.71%Perf 3Y-3.36%
Dividend Est.-EV/EBITDA20.35Sales past 3/5Y-0.74% 11.90%Gross Margin36.36%Volatility2.71% 3.04%Perf 5Y-12.50%
Dividend TTM-EV/Sales2.48EPS Y/Y TTM138.30%Oper. Margin3.72%ATR (14)5.19Perf 10Y51.73%
Dividend Ex-Date-Quick Ratio1.13Sales Y/Y TTM-9.49%Profit Margin2.15%RSI (14)69.11Recom2.00
Dividend Gr. 3/5Y-Current Ratio2.30EPS Q/Q14.53%SMA207.09%Beta0.74Target Price170.00
Payout0.00%Debt/Eq0.66Sales Q/Q-12.40%SMA5015.41%Rel Volume1.03Prev Close172.94
Employees13,000LT Debt/Eq0.64EarningsAug 06SMA20023.05%Avg Volume311.36KPrice171.96
IPO DateMar 31, 1992Option/ShortYes / YesEPS/Sales Surpr.12.42% 0.98%Net Debt/EBITDA4.01Volume320,758Change-0.57%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-21-26ReiteratedKeybancOverweight$164$182
Jun-15-26InitiatedBTIGBuy$170
May-27-26UpgradeNeedhamHoldBuy$165
Apr-27-26ReiteratedKeybancOverweight$180$164
Apr-17-26ReiteratedPiper SandlerOverweight$178$163
Feb-20-26ReiteratedKeybancOverweight$173$180
Feb-20-26ReiteratedPiper SandlerOverweight$153$178
Oct-21-25ReiteratedKeybancOverweight$198$173
Sep-10-25ReiteratedPiper SandlerOverweight$145$153
Aug-15-25InitiatedPiper SandlerOverweight$145
Latest News
Company

ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,1562,2302,3822,2592,2801,3161,2711,2661,400
Cost of Goods Sold Incl. D&A1,3721,4101,5571,5191,582825810794830
Gross Profit784820825740698491461472570
Selling, General and Administrative Excl. Other623625639607608303284277328
Research and Development858789859347434953
Other Operating Expense-515425401836390
Operating Income811074323-431239810722
Interest Expense88105107103711211
Unusual Expense
Non-Operating Income (Expense)162-22-11181
Net Income Before Taxes103-66-78-1141239711522
Income Taxes-38252-49-40201114-6
Consolidated Net Income461-118-30-741038710129
Net Income From Continuing Operations461-118-30-741038710129
Net Income461-118-30-741038710129
EPS (Recurring)1.870.03-4.83-1.23-3.114.864.164.901.33
EPS (Basic, Before Extraordinaries)1.870.03-4.83-1.23-3.114.864.164.901.33
EPS (Diluted)1.850.03-4.83-1.23-3.114.744.024.691.33
EBITDA26332743253192223194192272
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio92.954,852.7250.0753.3639.90172.65
Price To Sales Ratio1.991.601.561.061.663.793.543.103.61
Gross Margin36.3636.7734.6332.7630.6137.3136.2737.2840.71
Operating Margin3.764.801.811.02-1.899.357.718.451.57
Net Margin2.130.04-4.95-1.33-3.257.836.857.982.07
Shares Outstanding252524242421212122
Market Capitalization4,2993,5673,7242,3943,7804,9844,5043,9305,052
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$182.67$161.59$140.52$119.45$98.37 Close Price0.00M0.66M1.31M1.97M2.63MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Woolson DanielPresidentMay 22 '26Sale132.212,123280,68522,479May 22
Sanzone Virginia RuthVP, General CounselMay 14 '26Sale124.082,447303,62419,460May 15
Hoffmeister David FDirectorMay 13 '26Option Exercise0.001,25406,004May 13
KENNEDY KOLLEEN TDirectorMay 13 '26Option Exercise0.001,25404,539May 13
Greenberg David C.DirectorMay 13 '26Option Exercise0.001,25409,214May 13
Hernandez LaurieDirectorMay 13 '26Option Exercise0.001,25404,862May 13
Abbey DonaldDirectorMay 13 '26Option Exercise0.001,25406,004May 13
FINNEY ELISHA WDirectorMay 13 '26Option Exercise0.001,25405,249May 13
Greenberg David C.DirectorMay 12 '26Sale122.912,424297,9347,960May 13
Greenberg David C.DirectorMay 12 '26Option Exercise101.062,424244,96910,384May 13
Bonnell Brian MichaelChief Financial OfficerMar 15 '26Option Exercise0.0014,648076,097Mar 16
Voigtlander Christian B.Chief Operating OfficerMar 15 '26Option Exercise0.0014,648051,154Mar 16
Woolson DanielVP, GM-Infusion CapitalMar 15 '26Option Exercise0.002,924025,897Mar 16
Sousa BenChief Information OfficerMar 15 '26Option Exercise0.001,30006,044Mar 16
Sanzone Virginia RuthVP, General CounselMar 15 '26Option Exercise0.007,324024,330Mar 16
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.